[临床实践考量卡贝戈林在治疗垂体前列腺瘤]
1Department of Endocrinology, Huashan Hospital Fudan University, Shanghai 200040, China.
Zhonghua yi xue za zhi
|November 11, 2025
概括
更新的前乳腺瘤治疗指南建议将卡伯戈林作为抗烯素耐药病例的第一线选择. 长期使用卡伯戈林需要定期监测心脏门,因为潜在的不良影响.
科学领域:
- 内分泌学 在内分泌学.
- 神经瘤学神经瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 益生菌瘤是最常见的垂体神经内分泌瘤,起源于Pit-1血统.
- 目前的治疗方法包括手术,放射和药物,主要是多巴胺受体激动剂.
- 卡伯戈林是一种强大的D2受体激动剂,在国际上被认为是治疗乳腺癌的治疗方法.
研究的目的:
- 总结关于卡伯戈林的"关于垂体前瘤的诊断和治疗的共识"的2025年版更新.
- 为突出使用卡贝戈林在抗烯胺抗性前立腺瘤的新建议.
- 强调长期卡伯戈林治疗的安全监测,包括心脏和心理不良事件.
主要方法:
- "关于诊断和治疗垂体前瘤的共识 (2025年版) "指南的审查.
- 对卡伯戈林有效性和安全性的最新建议进行分析.
- 对内分泌学家在用卡伯戈林治疗益生菌瘤时的临床考虑的讨论.
主要成果:
- 卡伯戈林 (cabergoline) 推作为耐克里丁耐药患者的首选药物.
- 建议对长期服用高剂量卡伯戈林的患者进行定期心声图,以监测心脏门的健康状况.
- 该指南详细介绍了卡贝戈林的疗效,不良反应 (心脏膜疾病,冲动控制障碍) 以及在耐药病例中的使用情况.
结论:
- "2025年共识"提供了对卡贝戈林在益生菌瘤治疗中使用的关键更新.
- 临床医生必须仔细选择适应症,评估疗效,并监测安全性,尤其是在某些地区局部数据有限的情况下.
- 强调心脏监测和意识到潜在的心理副作用对于安全有效的长期卡伯戈林治疗至关重要.
相关概念视频
Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
447
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
447
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
797
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
797


